GLP-1 Market
LLY $1123.00 ▼ -0.1% NVO $44.01 ▼ -1.2% PFE $27.65 ▼ -0.5% VKTX $32.13 ▼ -1.7% KLRA $14.91 ▲ +0.5% GPCR $39.55 ▼ -4.1% RHHBY $53.19 ▼ -0.4% HIMS $27.44 ▼ -1.6% WW $14.78 ▼ -1.1%
Delayed · As of 9:20 AM

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

200mg FHND1002

Company
Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
None currently listed

Efficacy results: Not yet reported

No recruiting studies currently listed

See all studies for this drug

Data source: ClinicalTrials.gov · trial data as of Sep 11, 2026

Trial details
  • Enrolling by invitation NCT NCT06782958

    Safety, Tolerability, and Pharmacokinetics of FHND1002 Granules in Healthy Adults

    Not yet reported Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. 72 participants Est. completion 2025-06-05 1 site Stand-alone
    Other conditions: Amyotrophic Lateral Sclerosis (ALS)
    View official trial listing →
  • Not yet recruiting NCT NCT07138014

    FHND1002 for ALS Treatment: Phase 2

    Not yet reported Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. 180 participants Est. completion 2028-03-01 Stand-alone
    Other conditions: Amyotrophic Lateral Sclerosis (ALS)
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: 200mg FHND1002, 200mg FHND1002(postprandial), 100mg FHND1002, 150 mg FHND1002, 250mg FHND1002, 50mg FHND1002

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.